Global Pneumonia Testing Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 9.2% - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Pneumonia Testing Market by Method, Technology, Type, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering.

The global pneumonia testing market was valued at $932 million in 2016, and is estimated to reach $1,738 million by 2023, registering a CAGR of 9.2% from 2017 to 2023.

Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with deposition of cough in the lungs. It may even occur as a consequence to an upper tract infection. Frequently, it occurs in people with weakened immunity, and in geriatric population and children. Biotechnological methods can be approached for testing of pneumonia such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).

The report segments the pneumonia testing market by method, type, technology, end user, and region. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. Based on technology, it is categorized into enzyme-linked immunosorbent assay, immunofluorescence, western blot, polymerase chain reaction, immunohistochemistry (IHC), and others. By type, it is bifurcated into analyzers and consumables.

Increased awareness regarding early diagnosis, rise in popularity of POC testing, and surge in government expenditures on healthcare. However, limited detection capability and accuracy of some of the pneumonia testing products and regulatory and economic hurdles hamper the market growth. Some of the factors such as increase in adoption of molecular diagnostic testing and untapped markets in developing economies could open avenues of opportunities for the pneumonia testing market.

Key Players Profiled

Thermo Fisher Scientific Inc. Abbott Laboratories F-Hoffmann la Roche Ltd. Hologic Inc. bioMerieux Becton, Dickenson and Company Bio-Rad Laboratories Inc. Meridian Biosciences Quest Diagnostics Quidel AdvanDx Beckman Coulter Cepheid Concile Diamedix DiaSorin Fast-track Diagnostics SeraCare Trinity Biotech

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Pneumonia Testing Market, by Method

5 Pneumonia Testing Market, by Technology

6 Pneumonia Testing Market, by Type

7 Pneumonia Testing Market, by End User

8 Pneumonia Testing Market, by Geography

9 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/z2b72x/global_pneumonia?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612005954/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 10:07 AM/DISC: 06/12/2018 10:06 AM


Update hourly